Inhibitory effect of ethanol extract of Piper longum L. on rabbit platelet aggregation through antagonizing thromboxane A2 receptor

Masaya Iwashita, Masaki Saito, Yasunaga Yamaguchi, Ryoji Takagaki, Norimichi Nakahata

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Piper longum L. has been used as a crude drug for the treatment of disorders of poor peripheral blood circulation in Asia. However, the detailed mechanism of its action has not been clarified as yet. In the present study, we examined the effects of several extracts of Piper longum L. on rabbit platelet function. Thromboxane A2 receptor agonist U46619 caused rabbit platelet aggregation, which was potently inhibited by the ethanol or butanol extract of Piper longum L. The ethanol extract inhibited U46619-induced platelet aggregation in a concentration-dependent manner, but only weakly inhibited that induced by thrombin. The maximum response to U46619 was reduced by 100% ethanol extract concentration dependently, suggesting that the inhibitory mode of U46619-induced platelet aggregation by the ethanol extract was non-competitive. The extract also inhibited U46619-induced phosphoinositide hydrolysis with a similar concentration dependency to the platelet aggregation. Furthermore, the extract inhibited binding of [3H]SQ29548 to thromboxane A2 receptor in intact platelets in a concentration-dependent manner. These results suggest that Piper longum L. contains a constituent(s) that inhibits platelet aggregation as a non-competitive thromboxane A2 receptor antagonist.

Original languageEnglish
Pages (from-to)1221-1225
Number of pages5
JournalBiological and Pharmaceutical Bulletin
Volume30
Issue number7
DOIs
Publication statusPublished - 2007 Jul 1

Keywords

  • Piper longum L.
  • Platelet aggregation
  • Thromboxane A receptor

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Inhibitory effect of ethanol extract of Piper longum L. on rabbit platelet aggregation through antagonizing thromboxane A<sub>2</sub> receptor'. Together they form a unique fingerprint.

  • Cite this